Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin.
Ryan D CassadayDavid I MarksDaniel J DeAngeloElias J JabbourAnjali S AdvaniSusan O'BrienTao WangAlexander NeuhofErik VandendriesHagop M KantarjianWendy StockMatthias StelljesPublished in: British journal of haematology (2020)
Keyphrases
- acute lymphoblastic leukemia
- liver failure
- acute myeloid leukemia
- respiratory failure
- diffuse large b cell lymphoma
- multiple myeloma
- hodgkin lymphoma
- drug induced
- aortic dissection
- hepatitis b virus
- type diabetes
- intensive care unit
- extracorporeal membrane oxygenation
- mechanical ventilation
- glycemic control
- acute respiratory distress syndrome